Fenofibrate Exerts Protective Effects in Diabetic Retinopathy
Fenofibrate offers significant protective effects in diabetic retinopathy by reducing inflammation and oxidative stress, promoting autophagy, and inhibiting ferroptosis, making it a promising therapeutic option for managing the disease.
Authors
- Shimei Chen (ORCID: https://orcid.org/0000-0002-7734-8254)
- Fang Wei (ORCID: https://orcid.org/0000-0001-8964-1645)
- Qing Liu (ORCID: https://orcid.org/0000-0003-3173-9492)
- Dandan Sun (ORCID: https://orcid.org/0000-0001-8548-1525)
- Xun Xu (ORCID: https://orcid.org/0000-0002-4246-4343)
- Xiaoqian Wang (ORCID: https://orcid.org/0000-0002-4424-6024)
- Peiyu Liu (ORCID: https://orcid.org/0000-0001-8409-0944)
- Shuchang Zhang (ORCID: https://orcid.org/0000-0003-4065-1265)
Institutions
- Shanghai Jiao Tong University (CN)
- University of Lusaka (ZM)
- Renji Hospital (CN)
- Shanghai Eye Disease Prevention & Treatment Center (CN)
- Tongren Hospital (CN)
- Center for Visual Communication (United States) (US)
- National Clinical Research (US)
- Shanghai First People's Hospital (CN)
Publication Details
- Journal
- Current Eye Research
- Published
- 2025-06-18
- DOI
- https://doi.org/10.1080/02713683.2025.2516802
- Citations
- 4
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 6.83